These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7295478)

  • 21. [Treatment of postsurgical bone infections].
    Nentwig GH; Kniha H
    Fortschr Kiefer Gesichtschir; 1985; 30():35-7. PubMed ID: 3861535
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antibacterial therapy of purulent peritonitis: a prospective randomized study on the effects of antibiotics and taurolin, a new chemotherapeutic and antiendotoxic agent (author's transl)].
    Linder MM; Ott W; Wesch G
    Chir Forum Exp Klin Forsch; 1980; ():67-71. PubMed ID: 7389482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NMR studies and GC analysis of the antibacterial agent taurolidine.
    Knight BI; Skellern GG; Smail GA; Browne MK; Pfirrmann RW
    J Pharm Sci; 1983 Jun; 72(6):705-7. PubMed ID: 6875837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ["Taurolin-Gel" and Taurolin-Trockengel" in treatment of osseous tissue inflammation].
    Zawadziński S; Benke G; Eluszkiewicz S; Wasikowski A; Zarek S
    Chir Narzadow Ruchu Ortop Pol; 1990; 55(2):145-8. PubMed ID: 1369935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of post-traumatic osteomyelitis with Taurolin Gel].
    Kalas L; Kárpáti V
    Magy Traumatol Orthop Helyreallito Seb; 1987; 30(1):11-7. PubMed ID: 2882069
    [No Abstract]   [Full Text] [Related]  

  • 26. On the statistical evaluation of adherence assays.
    Woolfson AD; Gorman SP; McCafferty DF; Jones DS
    J Appl Bacteriol; 1987 Aug; 63(2):147-51. PubMed ID: 3308804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nebacetin and taurolin as intraoperative disinfectant solutions in surgery of the locomotor system (author's transl)].
    Burri C; Lob G; Rudzki M
    Aktuelle Traumatol; 1980 Apr; 10(2):65-72. PubMed ID: 6107015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of taurolin on endogenous immunity and pathogen elimination in human peritonitis].
    Billing A; Fröhlich D; Ruckdeschel G
    Langenbecks Arch Chir; 1992; 377(3):180-5. PubMed ID: 1619980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antioxidant status in experimental peritonitis: effects of alpha tocopherol and taurolin.
    Konukoglu D; Iynem H; Ziylan E
    Pharmacol Res; 1999 Mar; 39(3):247-51. PubMed ID: 10094852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Taurolin as an oral rinse. I. Antimicrobial effects in vitro and in vivo.
    Reynolds S; Moran J; Addy M; Wade WG; Newcombe R
    Clin Prev Dent; 1991; 13(2):13-7. PubMed ID: 1860285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Spectrum of indications and perioperative management in i. v. port-a-cath explantation--alternative administration of taurolin in case of i. v. port-a-cath infection].
    Weber M; Meyer F; Halloul Z
    Zentralbl Chir; 2009 Aug; 134(4):350-6. PubMed ID: 19688684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of local infection with taurolin].
    Burri C
    Aktuelle Probl Chir Orthop; 1990; 34():78-84. PubMed ID: 1978600
    [No Abstract]   [Full Text] [Related]  

  • 33. [The therapy of the postextraction syndrome with Taurolin. A controlled clinical study].
    Zimmermann M; Nentwig GH
    Schweiz Monatsschr Zahnmed; 1992; 102(11):1327-32. PubMed ID: 1470889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapy of purulent peritonitis. Documentation of 78 cases and experience with taurolin (author's transl)].
    Linder MM; Ott W; Wesch G; Wicki O; Marti MC; Moser G
    Langenbecks Arch Chir; 1981; 353(4):241-50. PubMed ID: 7230985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Taurolidine instillation as therapy for empyema thoracis. A prospective study of 50 patients.
    Conlan AA; Abramor E; Delikaris P; Hurwitz SS
    S Afr Med J; 1983 Oct; 64(17):653-5. PubMed ID: 6353621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The in vitro and in vivo activity of taurolin against anaerobic pathogenic organisms.
    Browne MK; Leslie GB; Pfirrman RW; Brodhage H
    Surg Gynecol Obstet; 1977 Dec; 145(6):842-6. PubMed ID: 201040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of taurolin in the prevention of septic complications in emergency abdominal surgery].
    Popović M; Dugalni D; Milićević M; Petrović M; Zuvela M; Knezević S; Janković Z
    Acta Chir Iugosl; 1991; 38(1):23-33. PubMed ID: 8701687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Taurolin as an oral rinse. II. Effects on in vitro and in vivo plaque regrowth.
    Reynolds S; Moran J; Wade WG; Addy M; Newcombe R
    Clin Prev Dent; 1991; 13(2):18-22. PubMed ID: 1860286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenges in ocular infectious diseases and the evolution of anti-infective therapy.
    Oguz E; Oguz H
    Surv Ophthalmol; 2004; 49(6):617-8; author reply 618. PubMed ID: 15530948
    [No Abstract]   [Full Text] [Related]  

  • 40. The mode of antibacterial action of some 'masked' formaldehyde compounds.
    Gidley MJ; Sanders JK; Myers ER; Allwood MC
    FEBS Lett; 1981 May; 127(2):225-7. PubMed ID: 7016592
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.